Abstract:The emergence of antimicrobial-resistant bacterial infections poses a significant threat to public health, necessitating the development of innovative and effective alternatives to antibiotics. Photodynamic therapy (PDT) and immunotherapy show promise in combating bacteria. However, PDT's effectiveness is hindered by its low specificity to bacteria, while immunotherapy struggles to eliminate bacteria in immunosuppressive environments. In this work, we introduce an innovative near-infrared antimicrobial nanoplatform (ZFC) driven by bacterial metabolism. ZFC, comprising d-cysteine-functionalized pentafluorophenyl bacteriochlorin (FBC-Cy) coordinated with Zn2+, is designed for antimicrobial photodynamic-immune therapy (aPIT) against systemic bacterial infections. By specifically targeting bacteria via d-amino acid incorporation into bacterial surface peptidoglycans during metabolism, ZFC achieves precise bacterial clearance in wound and pulmonary infections, exhibiting an antimicrobial efficacy of up to 90 % with minimal damage to normal cells under 750 nm light. Additionally, ZFC enhances the activation of antigen-presenting cells by 3.2-fold compared to control groups. Furthermore, aPIT induced by ZFC triggers systemic immune responses and establishes immune memory, resulting in a 1.84-fold increase in antibody expression against bacterial infections throughout the body of mice. In conclusion, aPIT prompted by ZFC presents a approach to treating bacterial infections, offering a broad-spectrum solution for systemic bacterial infections. STATEMENT OF SIGNIFICANCE: The new concept demonstrated focuses on an innovative near-infrared antimicrobial nanoplatform (ZFC) for antimicrobial photodynamic-immune therapy (aPIT), highlighting its reliance on bacterial metabolism and its non-damaging effect on normal tissues. ZFC efficiently targets deep-tissue bacterial infections by harnessing bacterial metabolism, thereby enhancing therapeutic efficacy while sparing normal tissues from harm. This approach not only clears bacterial infections effectively but also induces potent adaptive immune responses, leading to the eradication of distant bacterial infections. By emphasizing ZFC's unique mechanism driven by bacterial metabolism and its tissue-sparing properties, this work underscores the potential for groundbreaking advancements in antimicrobial therapy. Such advancements hold promise for minimizing collateral damage to healthy tissues, thereby improving treatment outcomes and mitigating the threat of antimicrobial resistance. This integrated approach represents a significant progress forward in the development of next-generation antimicrobial therapies with enhanced precision and efficacy.

Intracellular Antimicrobial Photodynamic Therapy: A Novel Technique for Efficient Eradication of Pathogenic Bacteria

Photodynamic Antimicrobial Chemotherapy with the Novel Amino Acid-Porphyrin Conjugate 4I: in Vitro and in Vivo Studies

Development of Photodynamic Antimicrobial Chemotherapy (PACT) for Clostridium difficile

An effective zinc phthalocyanine derivative for photodynamic antimicrobial chemotherapy

Household light source for potent photo-dynamic antimicrobial effect and wound healing in an infective animal model.

Advances in the Research of Photodynamic Antimicrobial Chemotherapy for Treating Methicillin-Resistant Staphylococcus Aureus Infection

Photodynamic antimicrobial chemotherapy with cationic phthalocyanines against Escherichia coli planktonic and biofilm cultures (vol 7, pg 40734, 2017)

Rapid killing of bacteria by a new type of photosensitizer

Intrabacterial Nitroreductase‐Activated Imaging and Persistently Illuminated Photodynamic Therapy for Intracellular Infection Theranostics

Antimicrobial Photodynamic Inactivation Mediated by a Class of Dual-Action Light-Activated Antibiotics: Tetracyclines is Potentiated by Potassium Iodide (conference Presentation)

Synergistic Antimicrobial Effects of Photodynamic Antimicrobial Chemotherapy and Gentamicin on Staphylococcus Aureus and Multidrug-Resistant Staphylococcus Aureus

Antimicrobial Photodynamic Therapy against Escherichia coli and Staphylococcus aureus Using Nanoemulsion-Encapsulated Zinc Phthalocyanine

Antimicrobial photodynamic therapy against Escherichia coli by exploiting endogenously produced Protoporphyrin IX- In vitro study

Antimicrobial Properties of a New Type of Photosensitizer Derived from Phthalocyanine Against Planktonic and Biofilm Forms of Staphylococcus Aureus.

Preparation and Antibacterial Ability of Photodynamic Antibacterial Nanoparticles with Ammonium Cationic Groups

Photodynamic Therapy under Diagnostic Control of Wounds with Antibiotic-Resistant Microflora

Cyclic Peptide Conjugated Photosensitizer for Targeted Phototheranostics of Gram-Negative Bacterial Infection.

A Near-Infrared Broad-Spectrum Antimicrobial Nanoplatform Powered by Bacterial Metabolic Activity for Enhanced Antimicrobial Photodynamic-Immune Therapy

Photodynamic Antimicrobial Chemotherapy for Staphylococcus Aureus and Multidrug-Resistant Bacterial Burn Infection in Vitro and in Vivo

Membrane Disruption-Enhanced Photodynamic Therapy Against Gram-Negative Bacteria by a Peptide-Photosensitizer Conjugate

Bacterial Infection Microenvironment Sensitive Prodrug Micelles with Enhanced Photodynamic Activities for Infection Control